Company: LGN
Filing Date: 2025-05-14
Form Type: DRS/A
Source: 0000950123-25-005247
Chunk: 300

Company: Legence Corp.
Filing Date: 2025-05-14
Form: DRS/A
Chunk 300
---
 IPO (1) |     |         Remain as 
 Profits Interests 
      post IPO (2) |     |  Delayed 
 Exit (3) |
| Expected dividend yield |     |           — % |     |               — % |     |      — % |
| Risk-free interest rate |     |          4.2% |     |              4.3% |     |     4.3% |
| Expected volatility     |     |           80% |     |               70% |     |      70% |
| Expected life (years)   |     |           0.5 |     |               3.5 |     |      5.0 |

| (1) | The Company completes an IPO, and Series A Profits Interests are settled. |

| (2) | The Company completes an IPO, and Series A Profits Interests remain outstanding. |

| (3) | The Company does not undergo a Change of Control in the foreseeable future. |

The compensation expense and corresponding income tax benefit for liability-classified Time Interests was as follows (in thousands):

|                                     |     | Year Ended December 31, |  2024 |     |   |   2023 |     |   |  2022 |
|:------------------------------------|:----|:------------------------|------:|:----|:--|-------:|:----|:--|------:|
| Selling, general and administrative |     | $                       | 3,786 |     | $ |  8,095 |     | $ | 4,283 |
| Cost of revenue                     |     |                         | 1,026 |     |   |  1,923 |     |   |   902 |
| Compensation expense                |     | $                       | 4,812 |     | $ | 10,018 |     | $ | 5,185 |
| Income tax benefit                  |     | $                       |     — |     | $ |    403 |     | $ |    44 |

F-46

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83 Legence Holdings LLC and Subsidiaries Notes to Consolidated Financial Statements The stock-based compensation liability for Time Interests as of December 31, 2024 and 2023 is $19.9 million and